Sharp rise in OD deaths demand better policies for those in their 20s, 30s: studyResearchers from the University of Toronto say the annual number of opioid-related deaths doubled in Canada to 6,200 between 2019 and the end of 2021. Are you a BC doctor using AI for patient care? Here's what you need to knowInterim guidance from the College of Physicians and Surgeons of British Columbia outlines ethical principles for the use of AI tools such as ChatGPT and Bard AI. Should reporting spousal abuse become mandatory? The stories of two patients highlight the complex challenges of intervening in such cases, finds Dr. Jabir Jassam. Can ketamine treat substance use disorders? A CADTH review looks into the evidence amid increased interest in using ketamine to treat mental illnesses. POLL: Should the Canada Health Act be reopened and revised? See what your colleagues say. Take our weekly doctor poll. College of Pharmacists of British Columbia responds to allegations pharmacies are offering kickbacks The college said it ‘shares the feeling of outrage toward those responsible’ after Globe and Mail and CBC News investigations alleged that some pharmacies in B.C. are giving vulnerable patients cash in return for using their stores. Is post-infectious myalgic encephalomyelitis due to ‘immune exhaustion’? Formerly called chronic fatigue syndrome, diagnosing post-infectious myalgic encephalomyelitis remains a challenge. Medical libraries are essential. So why are we imposing cuts on them? If you still envision libraries as rooms filled with books, it’s time to embrace the 21st century. Rimegepant (Nurtec ODT) now available for acute treatment of migraine Rimegepant is the second oral “gepant” for acute migraine to be marketed in Canada following ubrogepant (Ubrelvy). QUIZ: What do you know about hives and angioedema? Test your knowledge on common skin conditions. First Previous 136 137 138 139 140 Next Last
